Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

August 31, 2007

Study Completion Date

February 28, 2009

Conditions
Gastric UlcerDuodenal UlcerRheumatoid ArthritisOsteoarthritisLumbago
Interventions
DRUG

Esomeprazole

20mg once daily oral

DRUG

Placebo

once daily oral

Trial Locations (39)

Unknown

Research Site, Chiryū

Research Site, Seto

Research Site, Yotukaido

Research Site, Miyaodai

Research Site, Sapporo

Research Site, Akashi

Research Site, Itami

Research Site, Koto

Research Site, Nishinomiya

Research Site, Hitachi

Research Site, Morioka

Research Site, Sagamihara

Research Site, Yokohama

Research Site, Kōtari

Research Site, Kyoto

Research Site, Chiisagata

Research Site, Matsumoto

Research Site, Nagano

Research Site, Sasebo

Research Site, Beppu

Research Site, Ōita

Research Site, Ibara

Research Site, Hirakata

Research Site, Osaka

Research Site, Sakai

Research Site, Suita

Research Site, Takatsuki

Research Site, Kawagoe

Research Site, Saitama

Research Site, Fukuroi

Research Site, Hamamatsu

Research Site, Izunokuni

Research Site, Maikinohara

Research Site, Shizuoka

Research Site, Yaizu

Research Site, Shimotsuke

Research Site, Chiyoda City

Research Site, Koto

Research Site, Musashimurayama

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY